News

COVID-X Programme: Looking for data-driven solutions to overcome COVID-19 challenges

Published on: 04/06/2021

COVID-X Programme: Looking for data-driven solutions to overcome COVID-19 challenges
Covid-19
Member News

COVID-X will grant EU companies [Single Players] with 100K€ to validate their data solutions in one of our clinical partners. If the company brings in a healthcare provider that can validate the solution  [Team Players], the financial support will go up to 150K€. The challenges should be related to diagnosis, prognosis or follow-up of patients with COVID-19, or to a new open challenge.

COVID-X involves a consortium of 10 prominent partners from 7 different countries. The consortium includes organisations from different sectors, including clinical, technological, business and marketing. 

COVID-X bridges the gap between the European digital sector and healthcare providers. The programme aims to unlock the full capacity of artificial intelligence and data technology solutions to overcome COVID-19 challenges, fast-tracking projects to market and save lives.

Currently, the programme is looking for data-driven solutions to overcome COVID-19 challenges. 

Application Deadline is 22.07.2021.

NEWS​

Related News

New Round Tables announced to drive progress on EHDS and health AI

3 Jul 2025

The European Accessibility Act Is Here. Are You Ready?

2 Jul 2025
Why inclusive design is no longer optional – and how Big Motive can help you lead the way.

DTH-Lab Director: The G7 must act now to address the digital health transformation

2 Jul 2025
As digital platforms increasingly shape health systems and information flows, the G7 must lead in setting global standards to ensure safety, equity an...

InnoHSupport Open Calls

1 Jul 2025
Welcome to the InnoHSupport Open Calls!

Transformative Health Instrument Call 2025

1 Jul 2025
Apply to the Transformative Health Instrument (THI) Call 2025 if you are a growing and innovative healthcare start-up working on solutions that have s...

Longitude Prize on ALS

1 Jul 2025
The £7.5 million (~$10 million) Longitude Prize on ALS incentivises the use of AI-based approaches to transform drug discovery for amyotrophic lateral...

Become a member

Join ECHAlliance to amplify your organisation’s message, grow your networks, connect with innovators and collaborate globally.
 
First name *
Last Name *
Email Address *
Country *
Position *
First name *
Last Name *
Email Address *
Country *
Position *